NCT01714947View on ClinicalTrials.gov

Mass Balance, Pharmacokinetics and Metabolism Study of Alisertib

PHASE1CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

January 24, 2013

Primary Completion Date

April 4, 2013

Study Completion Date

June 14, 2013

Conditions
Advanced Solid TumorsLymphoma
Interventions
DRUG

[^14C]-alisertib

\[\^14C\]-alisertib oral solution

DRUG

alisertib

Alisertib enteric coated tablets

Trial Locations (1)

98418

Comprehensive Clinical Development, Tacoma

Sponsors
All Listed Sponsors
lead

Millennium Pharmaceuticals, Inc.

INDUSTRY